Advancing individualised therapies
The decoding of the genome has made it possible for molecular biology specialists to detect predispositions for illnesses and treat them accordingly.
Molecular
Iron oxide nanoparticles for biomedical MR imaging
Researchers open up new opportunities for cellular and molecular MR imaging.
Partnerships to personalise medicine
Peter Loescher has worked at the cutting edge of the pharmaceutical industry for 17 years. In the latter part of this period, for example, he headed Hoechst's division in Japan, where he was also spokesperson for the European pharmaceutical industry, negotiating with the Japanese government during its healthcare reform in 2002.
